特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

がん患者登録ソフトウェアの世界市場:市場機会分析および将来予測

Global Cancer Registry Software Market Size study, by Type, by Deployment Model, by Database Type, By Functionality, by End-User and Regional Forecasts 2019-2026

発行 Bizwit Research & Consulting LLP 商品コード 916180
出版日 ページ情報 英文
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=106.59円で換算しております。
がん患者登録ソフトウェアの世界市場:市場機会分析および将来予測 Global Cancer Registry Software Market Size study, by Type, by Deployment Model, by Database Type, By Functionality, by End-User and Regional Forecasts 2019-2026
出版日: 2019年11月08日 ページ情報: 英文
概要

当レポートでは、がん患者登録ソフトウェアの世界市場を調査し、市場の概要、タイプ、エンドユーザー、地域別の市場動向、市場規模の推移と予測、市場促進・阻害要因ならびに市場機会の分析、競合情勢、主要企業のプロファイルなど包括的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

  • 市場のスナップショット
  • グローバルおよびセグメントの市場予測、2017年-2026年(百万米ドル)
    • タイプ別
    • 展開モデル別
    • データベースタイプ別
    • 機能別
    • エンドユーザー別
    • 地域別
  • 主なトレンド
  • 予測方法
  • 調査の前提条件

第2章 市場の定義と範囲

  • 調査の目的
  • 市場の定義と範囲
    • 調査範囲
    • 産業の進化
  • 調査期間
  • 通貨換算レート

第3章 市場のダイナミクス

  • 市場の影響分析(2018-2026)
    • 成長要因
    • 市場の課題
    • 市場機会

第4章 市場の業界分析

  • ファイブフォースモデル
    • サプライヤーの交渉力
    • 買い手の交渉力
    • 新規参入の脅威
    • 代替品の脅威
    • 競合企業
    • ファイブフォースモデルへの将来的アプローチ(2016-2026)
  • PEST分析
    • 政治シナリオ
    • 経済シナリオ
    • 社会シナリオ
    • 技術シナリオ
  • 投資採用モデル
  • アナリストの推奨と結論

第5章 がん患者登録ソフトウェア市場:種類別

  • 市場のスナップショット
  • 種類、パフォーマンス-潜在性分析
  • 市場の推定値および予測、2016年-2026年(百万米ドル)
  • サブセグメント分析
    • スタンドアロン型ソフトウェア
    • 統合型ソフトウェア

第6章 がん患者登録ソフトウェア市場:展開モデル別

  • 市場のスナップショット
  • 展開モデル、パフォーマンス-潜在性分析
  • 市場の推定値および予測、2016年-2026年(百万米ドル)
  • サブセグメント分析
    • オンプレミス
    • クラウドベース

第7章 がん患者登録ソフトウェア市場:データベースタイプ別

  • 市場のスナップショット
  • 展開モデル、パフォーマンス別-潜在性分析
  • 市場の推定値および予測、2016年-2026年(百万米ドル)
    • 商用データベース
    • 公開データベース

第8章 がん患者登録ソフトウェア市場:機能別

  • 市場のスナップショット
  • 機能、パフォーマンス-潜在性分析
  • 市場の機能別予測、予測、2016年~2026年(百万米ドル)
    • 連邦/州政府規制遵守用
    • 患者ケア管理
    • 医学研究・臨床研究
    • 製品成果評価

第9章 がん患者登録ソフトウェア市場:エンドユーザー別

  • 市場のスナップショット
  • 展開モデル、パフォーマンス-潜在性分析
  • 市場の推定値および予測、2016年-2026年(百万米ドル)
    • 政府機関・TPA (事務代行会社)
    • 病院・診療所
    • 民間保険支払者
    • 製薬/バイオテクノロジー/医療機器企業
    • 研究センター

第10章 がん患者登録ソフトウェア市場:地域別

  • 地域市場のスナップショット
  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • その他
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • その他
  • 中南米
    • ブラジル
    • メキシコ
  • その他

第11章 競争状況

  • トップ市場戦略
  • 企業プロファイル
    • Onco, Inc.
    • C/Net Solutions
    • Elekta AB (PUB)
    • Rocky Mountain Cancer Data Systems
    • Electronic Registry Systems, Inc.
    • Mckesson Corporation

第12章 調査方法

  • 調査方法
    • データマイニング
    • 分析
    • 市場予測
    • 検証
    • 出版
  • 調査属性
  • 調査の前提条件
図表

List of Tables

  • TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL CANCER REGISTRY SOFTWARE MARKET
  • TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL CANCER REGISTRY SOFTWARE MARKET
  • TABLE 3. GLOBAL CANCER REGISTRY SOFTWARE MARKET, REPORT SCOPE
  • TABLE 4. YEARS CONSIDERED FOR THE STUDY
  • TABLE 5. EXCHANGE RATES CONSIDERED
  • TABLE 6. GLOBAL CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY REGION 2016-2026 (USD MILLION)
  • TABLE 7. GLOBAL CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY TYPE 2016-2026 (USD MILLION)
  • TABLE 8. GLOBAL CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY DEPLOYMENT MODEL 2016-2026 (USD MILLION)
  • TABLE 9. GLOBAL CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY DATABASE TYPE 2016-2026 (USD MILLION)
  • TABLE 10. GLOBAL CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY FUNCTIONALITY 2016-2026 (USD MILLION)
  • TABLE 11. GLOBAL CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY END-USER 2016-2026 (USD MILLION)
  • TABLE 12. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 13. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 14. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 15. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 16. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 17. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 18. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 19. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 20. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 21. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 22. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 23. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 24. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 25. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 26. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 27. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 28. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 29. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 30. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 31. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 32. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 33. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 34. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 35. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 36. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 37. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 38. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 39. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 40. U.S. CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 41. U.S. CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 42. U.S. CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 43. U.S. CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 44. U.S. CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 45. CANADA CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 46. CANADA CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 47. CANADA CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 48. CANADA CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 49. CANADA CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 50. UK CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 51. UK CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 52. UK CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 53. UK CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 54. UK CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 55. GERMANY CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 56. GERMANY CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 57. GERMANY CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 58. GERMANY CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 59. GERMANY CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 60. ROE CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 61. ROE CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 62. ROE CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 63. ROE CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 64. ROE CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 65. CHINA CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 66. CHINA CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 67. CHINA CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 68. CHINA CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 69. CHINA CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 70. INDIA CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 71. INDIA CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 72. INDIA CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 73. INDIA CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 74. INDIA CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 75. JAPAN CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 76. JAPAN CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 77. JAPAN CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 78. JAPAN CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 79. JAPAN CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 80. ROAPAC CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 81. ROAPAC CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 82. ROAPAC CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 83. ROAPAC CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 84. ROAPAC CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 85. BRAZIL CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 86. BRAZIL CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 87. BRAZIL CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 88. BRAZIL CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 89. BRAZIL CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 90. MEXICO CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 91. MEXICO CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 92. MEXICO CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 93. MEXICO CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 94. MEXICO CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 95. ROLA CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 96. ROLA CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 97. ROLA CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 98. ROLA CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 99. ROLA CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 100. ROW CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 101. ROW CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 102. ROW CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 103. ROW CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 104. ROW CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

List of Figures

  • FIG 1. GLOBAL CANCER REGISTRY SOFTWARE MARKET, RESEARCH METHODOLOGY
  • FIG 2. GLOBAL CANCER REGISTRY SOFTWARE MARKET, MARKET ESTIMATION BUILDING TYPES
  • FIG 3. GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS
  • FIG 4. GLOBAL CANCER REGISTRY SOFTWARE MARKET, KEY TRENDS 2018
  • FIG 5. GLOBAL CANCER REGISTRY SOFTWARE MARKET, GROWTH PROSPECTS 2019-2026
  • FIG 6. GLOBAL CANCER REGISTRY SOFTWARE MARKET, PORTERS 5 FORCE MODEL
  • FIG 7. GLOBAL CANCER REGISTRY SOFTWARE MARKET, PEST ANALYSIS
  • FIG 8. GLOBAL CANCER REGISTRY SOFTWARE MARKET, VALUE CHAIN ANALYSIS
  • FIG 9. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
  • FIG 10. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
  • FIG 11. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
  • FIG 12. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
  • FIG 13. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
  • FIG 14. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
  • FIG 15. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
  • FIG 16. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
  • FIG 17. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
  • FIG 18. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
  • FIG 19. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
  • FIG 20. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
  • FIG 21. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
  • FIG 22. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
  • FIG 23. GLOBAL CANCER REGISTRY SOFTWARE MARKET, REGIONAL SNAPSHOT 2016 & 2026
  • FIG 24. NORTH AMERICA CANCER REGISTRY SOFTWARE MARKET 2016 & 2026 (USD MILLION)
  • FIG 25. EUROPE CANCER REGISTRY SOFTWARE MARKET 2016 & 2026 (USD MILLION)
  • FIG 26. ASIA PACIFIC CANCER REGISTRY SOFTWARE MARKET 2016 & 2026 (USD MILLION)
  • FIG 27. LATIN AMERICA CANCER REGISTRY SOFTWARE MARKET 2016 & 2026 (USD MILLION)
  • FIG 28. GLOBAL CANCER REGISTRY SOFTWARE MARKET, COMPANY MARKET SHARE ANALYSIS (2018)
目次

Global Cancer Registry Software Market is valued approximately at USD 50.68 million in 2018 and is anticipated to grow with a healthy growth rate of more than 10.5% over the forecast period 2019-2026. Cancer registry is a computerized database which uses software solutions to organize, gather and store data of the cancer patients and evaluate cancer-specific upshots, situations and drug/medical device exposure. Growing number of cancer cases, increasing adoption of EHR, favorable government programs towards cancer and growing use of cancer patient registry data for post-marketing surveillance are the few factors responsible for high CAGR of the market over the forecast period. For instance, In 2018, it was estimated that there were 17.0 million new cancer cases and 9.5 million cancer deaths worldwide. The global burden of cancer is expected to grow to 27.5 million new cancer cases and 16.3 million cancer deaths by 2040 due to the growth and aging of the population, according to the International Agency for Research on Cancer (IARC). Owing to Tthe prevalence of cancer is on surging trend thereby escalating, the need for cancer registry software is also increased all over the world. Moreover, increasing number of accountable care organizations and growth of cloud-based cancer patient registry solutions is the major factor likely to create lucrative growth opportunity to the market in the upcoming years. However, privacy and data security-related concerns is one of the major factors anticipated to limiting the growth of global cancer registry software market during the forecast period.

The regional analysis of global Cancer Registry Software Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the rising prevalence of cancer, government funding initiatives to encourage the development of cancer registries and high investments in healthcare IT across the region. However, Asia-Pacific is anticipated to exhibit highest growth rate / CAGR over the forecast period 2019-2026.

Major market player included in this report are:

  • Onco, Inc.
  • C/Net Solutions
  • Elekta AB (PUB)
  • Rocky Mountain Cancer Data Systems
  • Electronic Registry Systems, Inc.
  • MckessonMcKesson Corporation

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

  • Standalone Software
  • Integrated Software

By Deployment Model:

  • On-premise
  • Cloud-Based

By Database Type:

  • Commercial Database
  • Public Database
  • By Functionality:
  • Cancer Reporting to Meet State and Federal Regulations
  • Patient Care Management
  • Medical Research & Clinical Studies
  • Product Outcome Evaluation

By End-User:

  • Government Organizations & Third-Party Administrators
  • Hospitals & Medical Practices
  • Private Players
  • Pharmaceutical, Biotechnology, and Medical Device Companies
  • Research Centers

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • Asia Pacific
  • China
  • India
  • Japan
  • Latin America
  • Brazil
  • Mexico
  • Rest of the World

Furthermore, years considered for the study are as follows:

  • Historical year - 2016, 2017
  • Base year - 2018
  • Forecast period - 2019 to 2026

Target Audience of the Global Cancer Registry Software Market in Market Study:

  • Key Consulting Companies & Advisors
  • Large, medium-sized, and small enterprises
  • Venture capitalists
  • Value-Added Resellers (VARs)
  • Third-party knowledge providers
  • Investment bankers
  • Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2017-2026 (USD Million)
    • 1.2.1. Cancer Registry Software Market, by Type, 2017-2026 (USD Million)
    • 1.2.2. Cancer Registry Software Market, by Deployment Model, 2017-2026 (USD Million)
    • 1.2.3. Cancer Registry Software Market, by Database Type, 2017-2026 (USD Million)
    • 1.2.4. Cancer Registry Software Market, by Functionality, 2017-2026 (USD Million)
    • 1.2.5. Cancer Registry Software Market, by End-User, 2017-2026 (USD Million)
    • 1.2.6. Cancer Registry Software Market, by Region, 2017-2026 (USD Million)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Cancer Registry Software Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Cancer Registry Software Market Dynamics

  • 3.1. Cancer Registry Software Market Impact Analysis (2018-2026)
    • 3.1.1. Market Drivers
    • 3.1.2. Market Challenges
    • 3.1.3. Market Opportunities

Chapter 4. Global Cancer Registry Software Market Type Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2016-2026)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Cancer Registry Software Market, by Type

  • 5.1. Market Snapshot
  • 5.2. Global Cancer Registry Software Market by Type, Performance - Potential Analysis
  • 5.3. Global Cancer Registry Software Market Estimates & Forecasts by Type 2016-2026 (USD Million)
  • 5.4. Cancer Registry Software Market, Sub Segment Analysis
    • 5.4.1. Standalone Software
    • 5.4.2. Integrated Software

Chapter 6. Global Cancer Registry Software Market, by Deployment Model

  • 6.1. Market Snapshot
  • 6.2. Global Cancer Registry Software Market by Deployment Model, Performance - Potential Analysis
  • 6.3. Global Cancer Registry Software Market Estimates & Forecasts by Deployment Model, 2016-2026 (USD Million)
  • 6.4. Cancer Registry Software Market, Sub Segment Analysis
    • 6.4.1. On-premises
    • 6.4.2. Cloud-based

Chapter 7. Global Cancer Registry Software Market, by Database Type

  • 7.1. Market Snapshot
  • 7.2. Global Cancer Registry Software Market by Deployment Model, Performance - Potential Analysis
  • 7.3. Global Cancer Registry Software Market Estimates & Forecasts by Deployment Model, 2016-2026 (USD Million)
    • 7.3.1. Commercial Databases
    • 7.3.2. Public Databases

Chapter 8. Global Cancer Registry Software Market, by Functionality

  • 8.1. Market Snapshot
  • 8.2. Global Cancer Registry Software Market by Functionality, Performance - Potential Analysis
  • 8.3. Global Cancer Registry Software Market Estimates & Forecasts by Functionality, 2016-2026 (USD Million)
    • 8.3.1. Cancer Reporting to Meet State and Federal Regulations
    • 8.3.2. Patient Care Management
    • 8.3.3. Medical Research & Clinical Studies
    • 8.3.4. Product Outcome Evaluation

Chapter 9. Global Cancer Registry Software Market, by End-User

  • 9.1. Market Snapshot
  • 9.2. Global Cancer Registry Software Market by Deployment Model, Performance - Potential Analysis
  • 9.3. Global Cancer Registry Software Market Estimates & Forecasts by Deployment Model, 2016-2026 (USD Million)
    • 9.3.1. Government Organizations & Third-Party Administrators
    • 9.3.2. Hospitals & Medical Practices
    • 9.3.3. Private Payers
    • 9.3.4. Pharmaceutical, Biotechnology, and Medical Device Companies
    • 9.3.5. Research Centers

Chapter 10. Global Cancer Registry Software Market, Regional Analysis

  • 10.1. Cancer Registry Software Market, Regional Market Snapshot
  • 10.2. North America Cancer Registry Software Market
    • 10.2.1. U.S. Cancer Registry Software Market
      • 10.2.1.1. Type breakdown estimates & forecasts, 2016-2026
      • 10.2.1.2. Deployment Model breakdown estimates & forecasts, 2016-2026
      • 10.2.1.3. Database Type breakdown estimates & forecasts, 2016-2026
      • 10.2.1.4. Functionality breakdown estimates & forecasts, 2016-2026
      • 10.2.1.5. End-User breakdown estimates & forecasts, 2016-2026
    • 10.2.2. Canada Cancer Registry Software Market
  • 10.3. Europe Cancer Registry Software Market Snapshot
    • 10.3.1. U.K. Cancer Registry Software Market
    • 10.3.2. Rest of Europe Cancer Registry Software Market
  • 10.4. Asia-Pacific Cancer Registry Software Market Snapshot
    • 10.4.1. China Cancer Registry Software Market
    • 10.4.2. India Cancer Registry Software Market
    • 10.4.3. Japan Cancer Registry Software Market
    • 10.4.4. Rest of Asia Pacific Cancer Registry Software Market
  • 10.5. Latin America Cancer Registry Software Market Snapshot
    • 10.5.1. Brazil Cancer Registry Software Market
    • 10.5.2. Mexico Cancer Registry Software Market
  • 10.6. Rest of The World Cancer Registry Software Market

Chapter 11. Competitive Intelligence

  • 11.1. Top Market Strategies
  • 11.2. Company Profiles
    • 11.2.1. Onco, Inc.
      • 11.2.1.1. Key Information
      • 11.2.1.2. Overview
      • 11.2.1.3. Financial (Subject To Data Availability)
      • 11.2.1.4. Product Summary
      • 11.2.1.5. Recent Developments
    • 11.2.2. C/Net Solutions
    • 11.2.3. Elekta AB (PUB)
    • 11.2.4. Rocky Mountain Cancer Data Systems
    • 11.2.5. Electronic Registry Systems, Inc.
    • 11.2.6. Mckesson Corporation

Chapter 12. Research Process

  • 12.1. Research Process
    • 12.1.1. Data Mining
    • 12.1.2. Analysis
    • 12.1.3. Market Estimation
    • 12.1.4. Validation
    • 12.1.5. Publishing
  • 12.2. Research Attributes
  • 12.3. Research Assumption